Sign In
Buy PODD
$162.06
+0.780 (+0.484%)
At Close: Jul 13, 2026
PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors Should Contact SueWallSt
10:19am, Tuesday, 14'th Jul 2026
Insulet's CEO and CFO Named as Individual Defendants Under Section 20(a) for Alleged Cumulative Losses Stemming from Defective Omnipod Manufacturing Controls Insulet's CEO and CFO Named as Individual
Lost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
10:09am, Tuesday, 14'th Jul 2026
NEW YORK, July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Insulet Corporation (NASDAQ: PODD). Shareholders who purchased shares of PODD during the class
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options If you purchased or acquired
PODD Court News: Insulet Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses
06:17am, Tuesday, 14'th Jul 2026
A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet's Omnipod products. NEW
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
New York, New York--(Newsfile Corp. - July 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February
/PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit
05:38pm, Monday, 13'th Jul 2026
NEW YORK, July 13, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and Ma
SAN DIEGO, July 13, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: POD
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:00pm, Monday, 13'th Jul 2026
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:20pm, Monday, 13'th Jul 2026
BENSALEM, Pa., July 13, 2026 /PRNewswire/ -- The Law Offices of Howard G.
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Monday, 13'th Jul 2026
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet C
PODD DEADLINE: Levi & Korsinsky Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline
10:00am, Monday, 13'th Jul 2026
Alert: Claims Focus on Alleged Defective Cannula Manufacturing That Caused Insulin Under-Delivery in Millions of Omnipod Devices Alert: Claims Focus on Alleged Defective Cannula Manufacturing That Cau
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ:PODD) and
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm
04:00am, Monday, 13'th Jul 2026
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
